Clyde, North Carolina Clinical Trials

A listing of Clyde, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11 clinical trials
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

open biopsy
lithium
monoclonal antibodies
vitamin d
fluorouracil
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 65 views
  • 27 Jul, 2021
  • +978 other locations
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

monoclonal antibodies
anaphylactic reactions
fluorouracil
atezolizumab
immunosuppressive
AdventHealth Infusion Center Haywood
 (1.9 away) Contact site
  • 1047 views
  • 29 Jul, 2021
  • +589 other locations
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

This phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread into the deep muscle of the bladder wall (muscle-invasive) or urothelial cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). Monoclonal antibodies recognizing and blocking …

AdventHealth Infusion Center Haywood
 (1.9 away) Contact site
  • 836 views
  • 30 Jul, 2021
  • +757 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

lung cancer
carcinoma
carboplatin
paclitaxel
adenocarcinoma
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 1103 views
  • 31 Jul, 2021
  • +1138 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

copanlisib
fgfr inhibitor
adrenaline
metastatic cancer
serum pregnancy test
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 6087 views
  • 29 Jul, 2021
  • +1020 other locations
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

This randomized phase III trial studies how well olanzapine with or without fosaprepitant work in preventing chemotherapy induced nausea and vomiting in cancer patients receiving chemotherapy that causes vomiting. Olanzapine and fosaprepitant dimeglumine may help control nausea and vomiting in patients during chemotherapy. Olanzapine is usually given in combination with …

dexamethasone
metastasis
antibiotics
cyclophosphamide
bilateral oophorectomy
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 109 views
  • 29 Jul, 2021
  • +603 other locations
Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian Fallopian Tube or Primary Peritoneal Cancer

This randomized phase II/III trial studies how well cediranib maleate and olaparib work when given together or separately, and compares them to standard chemotherapy in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has returned (recurrent) after receiving chemotherapy with drugs that contain platinum (platinum-resistant) or continued …

tumor cells
carcinoma
vascular endothelial growth factor
vegf
peritoneal cancer
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 1729 views
  • 30 Jul, 2021
  • +211 other locations
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

This phase II/III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiation and chemotherapy (cisplatin) result in significant improvement in overall survival (time being alive) and progression-free survival (time being alive without cancer) for patients with intermediate risk human papillomavirus (HPV) positive oropharynx cancer (throat cancer) that has …

AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 135 views
  • 30 Jul, 2021
  • +539 other locations
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer The PDIGREE Study

This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and nivolumab, followed by nivolumab with cabozantinib in patients with untreated renal cell carcinoma that has spread to other parts of the body. The addition of cabozantinib to the …

monoclonal antibodies
atezolizumab
carcinoma
nephrectomy
interleukin 2
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 157 views
  • 31 Jul, 2021
  • +677 other locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

germ cell tumor
leuprolide
adrenaline
beta-human chorionic gonadotropin
vasectomy
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 6047 views
  • 31 Jul, 2021
  • +814 other locations